Back
Saket Sambhav
•
ADJUVA LEGAL® • 2d
Trump’s 100% Pharma Tariff: A Wake-Up Call for India’s Innovation Backbone ⚕️ On Oct 1, the US will impose a 100% tariff on branded and patented pharmaceutical imports - UNLESS companies are actively building manufacturing plants in America. India exported $3.7B worth of pharma products to the US in just the first half of 2025. This isn’t just a trade shock - it’s a systemic signal. We’ve long been the world’s pharmacy. But are we ready to be the world’s inventor? This moment demands more than reaction - it demands reinvention. What do we tell our youth? That we’ll keep exporting generics while others patent the future? That we’ll stay affordable, but never foundational? No. We tell them: You are the generation that builds. You are the generation that invents. You are the generation that redefines India’s place in the world.
Replies (4)
More like this
Recommendations from Medial
VIKRAM VARAL
EXIM TRADE IN COMMOD... • 20d
Trump’s new executive order cutting tariffs on metals, pharma, and other goods 🔑 Key Highlights of the Order Tariff Cuts: Over 45 product categories to see reductions, including: 1. Metals: Nickel, gold, graphite (important for stainless steel
See More
Anirudh Gupta
CA Aspirant|Content ... • 2m
Hey, We are all aware that the USA is now imposing a 25% tariff + penalty on India's exports to their country?? Based on a news snippet I have seen ,an expert says that it won't have much impact on India. "how there's no impact of tariff on India"?
See More
Rohan Saha
Founder - Burn Inves... • 1m
Markets are on a good rise today mainly on the back of local news nobody knows exactly what changes will come in GST but investors are taking it as a positive sign just this one update has managed to ease out the concerns about US tariff pressure It
See More
Download the medial app to read full posts, comements and news.